Anna K. Petterson, a nominee for re-election, notified ImmunoPrecise Antibodies Ltd. that she has accepted a position with another company and, due to a potential conflict of interest, will no longer be acting as a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | 0.00% |
|
-0.99% | -41.52% |
06-27 | ImmunoPrecise Antibodies Ltd. Appoints Kristin Taylor as Permanent Chief Financial Officer | CI |
06-25 | ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.52% | 26.32M | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- Anna K. Petterson Do Not Act as a Director of ImmunoPrecise Antibodies Ltd